{"id":"NCT03879772","sponsor":"Organon and Co","briefTitle":"Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)","officialTitle":"Dose-Ranging Study of Mometasone Furoate Nasal Spray (SCH 32088) in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (Protocol C95-161)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1996-03-12","primaryCompletion":"1996-07-01","completion":"1996-07-01","firstPosted":"2019-03-19","resultsPosted":"2019-08-12","lastUpdate":"2022-02-09"},"enrollment":679,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Rhinitis, Allergic, Seasonal"],"interventions":[{"type":"DRUG","name":"Mometasone furoate nasal spray","otherNames":["Nasonex®","MK-0887","SCH 032088"]},{"type":"DRUG","name":"Beclomethasone dipropionate nasal spray","otherNames":["Vancenase®"]},{"type":"DRUG","name":"Placebo nasal spray","otherNames":[]},{"type":"DRUG","name":"Chlorpheniramine maleate syrup","otherNames":["ChlorTrimeton Syrup"]}],"arms":[{"label":"MFNS 25 mcg QD","type":"EXPERIMENTAL"},{"label":"MFNS 100 mcg QD","type":"EXPERIMENTAL"},{"label":"MFNS 200 mcg QD","type":"EXPERIMENTAL"},{"label":"BDP 84 mcg BID","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to identify the lowest dosage of mometasone furoate nasal spray (MFNS) that provided adequate efficacy with an acceptable safety profile for children (ages 6-11) with seasonal allergic rhinitis (SAR). The MFNS dose levels of 25, 100, and 200 mcg QD were compared with beclomethasone dipropionate (BDP), as an active control, and placebo.","primaryOutcome":{"measure":"Change From Baseline in the Total Nasal Symptom Score (TNSS) at Day 8 as Assessed by Investigator","timeFrame":"Baseline (Day 1) and Day 8","effectByArm":[{"arm":"MFNS 25 mcg QD","deltaMin":7.8,"sd":1.7},{"arm":"MFNS 100 mcg QD","deltaMin":8.1,"sd":1.7},{"arm":"MFNS 200 mcg QD","deltaMin":7.9,"sd":1.6},{"arm":"BDP 84 mcg BID","deltaMin":8,"sd":1.7},{"arm":"Placebo","deltaMin":8,"sd":1.5}],"pValues":[{"comp":"OG000 vs OG001","p":"0.95"},{"comp":"OG000 vs OG002","p":"0.78"},{"comp":"OG000 vs OG003","p":"0.98"},{"comp":"OG000 vs OG004","p":"0.01"},{"comp":"OG001 vs OG002","p":"0.82"},{"comp":"OG001 vs OG003","p":"0.98"},{"comp":"OG001 vs OG004","p":"0.01"},{"comp":"OG002 vs OG003","p":"0.8"},{"comp":"OG002 vs OG004","p":"0.02"},{"comp":"OG003 vs OG004","p":"0.01"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":137},"commonTop":["Headache","Asthma","Cough","Oropharyngeal pain","Epistaxis"]}}